Status:
RECRUITING
Mindfulness-Based Interventions for OCD
Lead Sponsor:
Sunnybrook Health Sciences Centre
Collaborating Sponsors:
St. Joseph's Healthcare Hamilton
McMaster University
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Obsessive-compulsive disorder (OCD) is a severe and debilitating anxiety disorder afflicting about 2% of the population. It is characterized by the presence of recurrent obsessions and/or compulsions ...
Detailed Description
Cognitive Behavioural Therapy (CBT) is a first line psychological treatment for OCD with estimated response rates of between 70-80%. However, there are still a substantial number of treatment non-resp...
Eligibility Criteria
Inclusion
- experiencing clinically significant obsessive-compulsive symptoms based on the Yale-Brown Obsessive Compulsive Scale (YBOCS; score \> 17)
- if on medications for OCD, must be stabilized, i.e. are currently receiving an adequate dose (equivalent of 40mg/day of fluoxetine) for an adequate duration (at least 8 weeks of treatment) prior to the initiation of the study.
Exclusion
- concurrent diagnosis of a severe mood disorder, schizophrenia or other psychotic disorders, or substance abuse/dependence
- suspected organic pathology
- an active comorbid medical condition that may require urgent intervention during the treatment.
Key Trial Info
Start Date :
November 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT04914923
Start Date
November 9 2021
End Date
September 1 2025
Last Update
November 27 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6
2
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5